VTGN Financials
VistaGen Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.25
Market Cap
$28.12M
P/E Ratio
-0.1
EPS
$-1.71
Income Statement Highlights
Most Recent Quarter: 2025-03-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-51.42M
EPS (Diluted)
$-1.67
Balance Sheet Highlights
Total Assets
$84.34M
Total Liabilities
$13.95M
Shareholders Equity
-
Cash & Equivalents
$67.13M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-42.10M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-6947.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is VTGN revenue?
View VTGN's income statement for detailed revenue data.
Is VTGN profitable?
VTGN reported a loss of $51.42M in the most recent quarter. The net profit margin is -6947.2%.
What is VTGN market cap?
VTGN has a market capitalization of $28.12M, making it a small-cap stock.
Does VTGN have debt?
View VTGN's balance sheet for debt information.
What is VTGN cash flow?
Cash flow data is available in the full financial statements.